EDARBYCLOR

This brand name is authorized in United States. It is also authorized in Canada, Hong Kong SAR China.

Active ingredients

The drug EDARBYCLOR contains a combination of these active pharmaceutical ingredients (APIs):

1	Azilsartan medoxomil UNII WEC6I2K1FC - AZILSARTAN KAMEDOXOMIL
	Azilsartan medoxomil is an orally active prodrug that is rapidly converted to the active moiety, azilsartan, which selectively antagonises the effects of angiotensin II by blocking its binding to the AT1 receptor in multiple tissues. Angiotensin II is the principal pressor agent of the RAAS, with effects that include vasoconstriction, stimulation of synthesis and release of aldosterone, cardiac stimulation, and renal reabsorption of sodium.
	Read more about Azilsartan medoxomil
2	Chlortalidone UNII Q0MQD1073Q - CHLORTHALIDONE
	Chlortalidone is a benzothiadiazine (thiazide)-related diuretic with a long duration of action.
	Read more about Chlortalidone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EDARBYCLOR Tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09DA09		C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DA Angiotensin II antagonists and diuretics
Discover more medicines within C09DA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02397749, 02397765
HK	Department of Health Drug Office	62249, 62250
US	FDA, National Drug Code	60631-412, 60631-425